Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 291

Results For "EY"

3138 News Found

Telangana commences drone delivery of vaccines from Sept 9
News | September 09, 2021

Telangana commences drone delivery of vaccines from Sept 9

The much-awaited drone delivery trials for the delivery of medicines and vaccines will be held in Vikarabad, Hyderabad from 9th September till 17th October.


Novavax initiates Phase 1/2 trials combining vaccine for Covid-19 and seasonal influenza
Biotech | September 09, 2021

Novavax initiates Phase 1/2 trials combining vaccine for Covid-19 and seasonal influenza

First participants enrolled in Phase 1 clinical trial of combination NanoFlu/NVX-CoV2373 vaccine with Matrix-M adjuvant. The Phase 1/2 study will also evaluate immunogenicity and safety


Eirion Therapeutics mandates HTL Biotechnology to be its exclusive Botulinum API manufacturer.
Biotech | September 09, 2021

Eirion Therapeutics mandates HTL Biotechnology to be its exclusive Botulinum API manufacturer.

HTL will build, validate and operate a botulinum manufacturing facility in the US


Equipment shortage and overpriced APIs pinch the pharma industry
News | September 09, 2021

Equipment shortage and overpriced APIs pinch the pharma industry

A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges


Sandoz enters agreement for oncology biosimilar medicine bevacizumab
Drug Approval | September 09, 2021

Sandoz enters agreement for oncology biosimilar medicine bevacizumab

Sandoz is committed to building on its leading generic and biosimilar oncology portfolio to further expand patient access while contributing to the sustainability of healthcare systems


TCS leads in Life Sciences operations services: Everest group
Digitisation | September 08, 2021

TCS leads in Life Sciences operations services: Everest group

TCS provides clinical research services such as clinical data management, regulatory affairs, pharmacovigilance, risk-based monitoring, biostatistics and programming, medical writing, medical affairs and medico marketing, and health economics and outcomes research


Biocon settles suit with Celgene for generic Revlimid
Biotech | September 08, 2021

Biocon settles suit with Celgene for generic Revlimid

Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020


Navitas Life Sciences acquires its 200th customer
Digitisation | September 08, 2021

Navitas Life Sciences acquires its 200th customer

First launched in 2005, pharmaREADY is a fully integrated, regulatory compliant, web-based platform to create, view, and manage global regulatory submissions


Metropolis Healthcare opens a new testing centre in Latur, Maharashtra
Healthcare | September 08, 2021

Metropolis Healthcare opens a new testing centre in Latur, Maharashtra

The lab will offer over 4,000 clinical tests and profiles and can conduct over 20,000 sample tests per month.


Sanofi buys Kadmon to grow its transplant business
Biotech | September 08, 2021

Sanofi buys Kadmon to grow its transplant business

It adds Rezurock (belumosudil) an FDA-approved, first-in-class treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD)